Back to Endocrinology
Endocrinologyv2009Evidence-Based

Edmonton Obesity Staging System (EOSS)

Stratifies the presence and severity of obesity-related health impairments across medical, functional, and psychological domains to guide treatment decisions and predict outcomes.

Clinical Input Parameters

stage
stage
stage
Clinical Assessment
Awaiting Parameters
eoss stage
—stage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Edmonton Obesity Staging System (EOSS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

EOSS Stage = max(obesity_risk_factors, physical_symptoms, psychological_symptoms). The highest stage rating across all three domains determines the final EOSS stage.

Clinical Pearls & Practice Notes

  • The EOSS provides a more comprehensive assessment of obesity-related health risk than BMI alone.
  • The system evaluates obesity across three key domains: medical risk factors, physical function, and psychological health.
  • Each domain is independently assessed and scored from 0-4, with the highest score determining the overall stage.
  • Stage determination is based on the most severe impairment across any domain, not an average.
  • Higher EOSS stages are associated with increased mortality risk independent of BMI.
  • The system can help guide treatment intensity and resource allocation for obesity management.
  • EOSS staging has been validated for predicting surgical outcomes and long-term mortality.
  • The tool is designed to be used in conjunction with, not as a replacement for, BMI classification.
  • Clinical assessment should consider individual patient factors beyond EOSS staging.
  • Regular reassessment is recommended as obesity-related health status may change over time.
  • The system can help identify patients who may benefit from more aggressive interventions.
  • EOSS staging may be particularly useful for prioritizing patients for bariatric surgery evaluation.
  • The framework encourages comprehensive evaluation of obesity-related health impacts.
  • Patients with higher EOSS stages require more intensive, multidisciplinary management approaches.

Evidence & Literature Citations

  1. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289-95. doi: 10.1038/ijo.2009.2.
  2. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059-66. doi: 10.1503/cmaj.110387.
  3. Aasheim ET, Aylwin SJ, Radhakrishnan ST, Sood AS, Jovanovic Z, Olbers T, et al. Assessment of Obesity Beyond Body Mass Index to Guide Treatment. Curr Cardiol Rep. 2017;19(5):33. doi: 10.1007/s11886-017-0849-1.
  4. Canning KL, Brown RE, Jamnik VK, Salmon A, Ardern CI, Kuk JL. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care. 2017;5(1):e000379. doi: 10.1136/bmjdrc-2016-000379.

Score Interpretation Ranges

Stage 00 – 0 pts

No obesity-related health impairments

Stage 11 – 1 pts

Mild obesity-related health impairments

Stage 22 – 2 pts

Moderate obesity-related health impairments

Stage 33 – 3 pts

Severe obesity-related health impairments

Stage 44 – 4 pts

End-stage obesity-related health impairments

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.